🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Qara › Ohio › Cincinnati

Qorannoo klinikaalii Dhibee Qara Cincinnati, OH keessatti

Qorannoo 19 Dhibee Qara f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04181060

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • fi 3 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Namoota walitti qabaa jiraSadarkaa 3
  • University of Cincinnati Cancer Center, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Namoota walitti qabaa jiraSadarkaa 3
  • TriHealth Cancer & Blood Institute Research, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06881784

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Namoota walitti qabaa jiraSadarkaa 3
  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2/3
  • The Christ Hospital Cancer Center, Cincinnati
  • University of Cincinnati Medical Center, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • USO - Oncology Hematology Care, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • The Christ Hospital Cancer Center, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06712355

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Xencor Investigative Site, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT05433142

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Cincinnati Medical Center, Cincinnati
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Cincinnati, Cincinnati
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05361174

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • The Christ Hospital, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT06040541

MYLUNG Consortium Part 3: Observational Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Oncology Hematology Care Clinical Trials, LLC, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT05885698

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Namoota walitti qabaa jiraSadarkaa 1/2
  • Christ Hospital Cancer Center, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT05379985

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Cincinnati
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.

Namoota walitti qabaa jiraSadarkaa 2
  • The Christ Hospital, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Onk-2025 · NCT07207395

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Cincinnati, Cincinnati
Umuriin 29 hanga 85 · Saalaa hunda · Haaromfame 13-Sad-2024 · NCT06426628

Qorannoo Dhibee Qara magaalota biroo keessatti

Qorannoo biroo Cincinnati keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.